Skip to main content
. 2021 Jun 16;9(2):114–122. doi: 10.2478/jtim-2021-0026

Table 2.

Patient demographics

Factor N=1072 Factor N=1072


Mean ± SD / N (%) Mean ± SD / N (%)
Age (yr) 61.41 ± 15.77 Accompanying symptoms
Male gender 779 (72.67) Chest pain 66 (6.16)
Body mass index (kg/m2) 23.02 ± 4.88 Confusion 34 (3.17)
Comorbidity Syncope 93 (8.68)
None 77(7.18) Laboratory (on admission)
Coronary heart disease 149 (13.90) Hemoglobin 89.51 ± 29.78
Atrial fibrillation 24 (2.24) Albumin 34.10 ± 8.09
Hypertension 346 (32.28) Hemoglobin 89.51 ± 29.78
Cirrhosis 271 (25.28) Albumin 34.10 ± 8.09
Diabetes mellitus 197 (18.38) INR 1.36 ± 1.35
Chronic respiratory disease 30 (2.80) BUN 11.89±8.16
Chronic kidney disease 46 (4.29) Serum creatinine 94.61±108.12
Stroke 93 (8.68) No endoscopy 261 (24.35)
Gastrointestinal tumors 54 (5.04) Endoscopy
Any malignancies except GI 59 (5.50) Varices bleeding 202 (18.84)
Medication Peptic ulcer bleeding 412 (38.43)
PPI 93 (8.68) Esophagitis/gastritis/duodenitis 189 (17.63)
Aspirin 145 (13.53) Mallory–Weiss syndrome 38 (3.54)
NSAIDs 83 (7.74) Upper gastrointestinal tumors 26 (2.43)
Anticoagulant drugs 31 (2.89) Other finding 50 (4.66)
Vital signs and consciousness No abnormality seen 7 (0.65)
SBP (mmHg) 115.86 ± 23.79 Treatment after admission
DBP (mmHg) 69.13±27.62 RBC transfusion 506 (47.20)
HR (bpm) 92.20 ± 19.40 Endoscope treatment 319 (29.76)
GCS 14.85 ± 0.78 Interventional radiography 43 (4.01)
Onset symptoms Emergency surgery 28 (2.61)
Hematesis 559 (52.15) Outcome
Coffee ground material 75 (7.00) 90-Day mortality 117 (10.91)
Melaena 827 (77.15) Rebleeding 129 (12.03)

SD: standard deviation; GI: gastrointestinal; PPI: proton pump inhibitor; NSAIDs: nonsteroidal anti-inflammatory drugs; SBP: systolic blood pressure; DBP: diastolic blood pressure; HR: heart rate; GCS: Glasgow coma scale; INR: international normalized ratio; BUN: blood urea nitrogen; RBC: red blood cell.